




Searching News Database: Idenix Pharmaceuticals
HSMN NewsFeed - 15 Dec 2016
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
HSMN NewsFeed - 5 Mar 2015
Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel
Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel
HSMN NewsFeed - 5 Aug 2014
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
HSMN NewsFeed - 14 Mar 2014
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
HSMN NewsFeed - 28 Jan 2014
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
HSMN NewsFeed - 6 Jan 2014
Idenix Pharmaceuticals Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer
Idenix Pharmaceuticals Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 2 Dec 2013
Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences
Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences
HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
HSMN NewsFeed - 10 Jun 2013
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
HSMN NewsFeed - 5 Jun 2012
Kinex Pharmaceuticals Appoints Dr. Jean-Pierre Sommadossi to the Board of Directors
Kinex Pharmaceuticals Appoints Dr. Jean-Pierre Sommadossi to the Board of Directors
HSMN NewsFeed - 5 Apr 2010
OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board of Directors
OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board of Directors
HSMN NewsFeed - 28 Sep 2007
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
HSMN NewsFeed - 13 Jul 2007
Valopicitabine Development Program Placed on Clinical Hold in the United States
Valopicitabine Development Program Placed on Clinical Hold in the United States
HSMN NewsFeed - 30 Apr 2007
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
HSMN NewsFeed - 20 Mar 2007
Idenix Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
Idenix Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
HSMN NewsFeed - 2 Mar 2007
SEBIVO(R) (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B
SEBIVO(R) (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B
HSMN NewsFeed - 7 Dec 2006
Norman C. Payson, M.D., Elected to Board of Directors of Idenix Pharmaceuticals
Norman C. Payson, M.D., Elected to Board of Directors of Idenix Pharmaceuticals
HSMN NewsFeed - 26 Oct 2006
Idenix Pharmaceuticals Announces Strategic Collaboration To Enhance Hepatitis C Pipeline
Idenix Pharmaceuticals Announces Strategic Collaboration To Enhance Hepatitis C Pipeline
HSMN NewsFeed - 8 Sep 2006
Abraxis BioScience Names Leadership Team for Its Abraxis Pharmaceutical Products Division
Abraxis BioScience Names Leadership Team for Its Abraxis Pharmaceutical Products Division
HSMN NewsFeed - 15 May 2006
ESBATech AG Announces Appointment of James Egan as Chief Business Officer
ESBATech AG Announces Appointment of James Egan as Chief Business Officer
Additional items found! 19

Members Archive contains
19 additional stories matching:
Idenix Pharmaceuticals
(Password required)
Idenix Pharmaceuticals
(Password required)